HCPCS Level IItemporaryActive
Q2056
Ciltacabtagene car-pos t
BETOS: O1D
Effective: 2022-10-01
Referenced in 1 policies
Description
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
Excluded
This code is excluded from the Medicare Physician Fee Schedule.
Coverage Policies